Risks of developing psychiatric disorders in pediatric patients with psoriasis
Kimball, Alexa B., MD, Wu, Eric Q., PhD, Guérin, Annie, MSc, Yu, Andrew P., PhD, Tsaneva, Magda, BA, Gupta, Shiraz R., PharmD, Bao, Yanjun, PhD, Mulani, Parvez M., PhD
Published in Journal of the American Academy of Dermatology (01.10.2012)
Published in Journal of the American Academy of Dermatology (01.10.2012)
Get full text
Journal Article
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis
Kimball, Alexa Boer, MD, MPH, Yu, Andrew P., PhD, Signorovitch, James, PhD, Xie, Jipan, MD, PhD, Tsaneva, Magda, BA, Gupta, Shiraz R., PharmD, MPH, Bao, Yanjun, PhD, Mulani, Parvez M., PhD
Published in Journal of the American Academy of Dermatology (01.02.2012)
Published in Journal of the American Academy of Dermatology (01.02.2012)
Get full text
Journal Article
Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial
COLOMBEL, Jean-Frédéric, SANDBORN, William J, RUTGEERTS, Paul, KAMM, Michael A, YU, Andrew P, WU, Eric Q, POLLACK, Paul F, LOMAX, Kathleen G, JINGDONG CHAO, MULANI, Parvez M
Published in The American journal of gastroenterology (01.05.2009)
Published in The American journal of gastroenterology (01.05.2009)
Get full text
Journal Article
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: Comparison of adverse event–free response days in the CHAMPION trial
Reich, Kristian, MD, PhD, Signorovitch, James, PhD, Ramakrishnan, Karthik, MPH, Yu, Andrew P., PhD, Wu, Eric Q., PhD, Gupta, Shiraz R., PharmD, MPH, Bao, Yanjun, PhD, Mulani, Parvez M., PhD
Published in Journal of the American Academy of Dermatology (01.12.2010)
Published in Journal of the American Academy of Dermatology (01.12.2010)
Get full text
Journal Article
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
Colombel, Jean–Frédéric, Rutgeerts, Paul J, Sandborn, William J, Yang, Mei, Camez, Anne, Pollack, Paul F, Thakkar, Roopal B, Robinson, Anne M, Chen, Naijun, Mulani, Parvez M, Chao, Jingdong
Published in Clinical gastroenterology and hepatology (01.03.2014)
Published in Clinical gastroenterology and hepatology (01.03.2014)
Get full text
Journal Article
Comparative Effectiveness Without Head-to-Head Trials: A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept
Signorovitch, James E., Wu, Eric Q., Yu, Andrew P., Gerrits, Charles M., Kantor, Evan, Bao, Yanjun, Gupta, Shiraz R., Mulani, Parvez M.
Published in PharmacoEconomics (01.01.2010)
Published in PharmacoEconomics (01.01.2010)
Get full text
Journal Article
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial
Louis, Edouard, Löfberg, Robert, Reinisch, Walter, Camez, Anne, Yang, Mei, Pollack, Paul F., Chen, Naijun, Chao, Jingdong, Mulani, Parvez M.
Published in Journal of Crohn's and colitis (01.02.2013)
Published in Journal of Crohn's and colitis (01.02.2013)
Get full text
Journal Article
Web Resource
Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities: Subanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Kimball, Alexa B., Bensimon, Arielle G., Guerin, Annie, Yu, Andrew P., Wu, Eric Q., Okun, Martin M., Bao, Yanjun, Gupta, Shiraz R., Mulani, Parvez M.
Published in American journal of clinical dermatology (01.01.2011)
Published in American journal of clinical dermatology (01.01.2011)
Get full text
Journal Article
Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)
Sussman, Daniel A., Kubiliun, Nisa, Mulani, Parvez M., Chao, Jingdong, Gillis, Carol A.T., Yang, Mei, Lu, Mei, T. Abreu, Maria
Published in Inflammatory bowel diseases (01.11.2012)
Published in Inflammatory bowel diseases (01.11.2012)
Get full text
Journal Article
Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn’s Disease
Yu, Andrew P., Johnson, Scott, Wang, Si-Tien, Atanasov, Pavel, Tang, Jackson, Wu, Eric, Chao, Jingdong, Mulani, Parvez M.
Published in PharmacoEconomics (01.01.2009)
Published in PharmacoEconomics (01.01.2009)
Get full text
Journal Article
Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease
Loftus, Jr, Edward V, Johnson, Scott J, Yu, Andrew P, Wu, Eric Q, Chao, Jingdong, Mulani, Parvez M
Published in European journal of gastroenterology & hepatology (01.11.2009)
Published in European journal of gastroenterology & hepatology (01.11.2009)
Get more information
Journal Article
Greater refill adherence to adalimumab therapy for patients using specialty versus retail pharmacies
Liu, Yifei, Yang, Mei, Chao, Jingdong, Mulani, Parvez M.
Published in Advances in therapy (01.08.2010)
Published in Advances in therapy (01.08.2010)
Get full text
Journal Article